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curious that over 30 pages are allocated to insulinomas and
virtually the same to all the other gastrointestinal and panc-
reatic endocnne tumours.
As I have already hinted, the only major omission that I
can find is the limited reference to the use of octreoscan as a
diagnostic agent, which in Europe has become an essential
part of the modern diagnostic protocol for the investigation
of neuroendocrine cancers. However, this can clearly be
updated in future editions, as I am sure this will reach a
second edition. Furthermore, in a future edition a little more
emphasis could be included on the non-surgical therapies of
these cancers.
Who is going to buy this book? Reference libraries should
consider this a must, and it will certainly be purchased by
oncologists, endocrinologists and surgical oncologists with an
interest in thyroid and endocrine cancers. However, the
general oncologist is probably not going to have this on his
shelf. It is also unfortunate that within the next year there is
going to be a rival European book published which is likely
to cover the same ground. However, it may well be that the
volumes are complementary rather than directly rivalling
each other.
In conclusion, this is an excellent book which plugs a gap
that needed filling. It is a must for the reference library and a
must for those rare oncologists who have a particular interest
in endocrine malignancies.
NS Reed
Virm and Cacer
Edited by AC Minson, JC Neil and MA McCrae, Camb-
ridge: Cambridge University Press, 1994, 309 pp. £55. ISBN
0-52145472-7.
The story of viruses and cancer is important for two distinct
reasons. First, some 15% or more of human cancer incidence
is linked with virus infection. Major malignancies in the
world, such as cancer of the uterine cervix, primary liver
cancer, nasopharyngeal carcinoma (NPC) and several forms
of adult T-cell leukaemias and lymphomas, have viruses as
an essential component of their aetiology and pathogenesis.
Second, oncogenic viruses opened up cancer genetics.
Oncogenes were first found in retroviruses long bef6re it was
realised that the viruses had purloined cellular genes.
Tumour-suppressor proteins were first identified through the
study of DNA viruses, as viral proteins such as E6 and E7 of
the human papillomaviruses sequester the Rb and p53 pro-
teins, which is the phenotypic equivalent of a genetic knock-
out. Thus, studies of oncogenic viruses have had a
significance far beyond that proportion of cancer actually
caused by them.
This volume on viruses and cancer represents papers given
at the 51st Symposium of the British Society for General
Microbiology. It provides a useful overview of current
research into oncogenic viruses. While some chapters are
broad reviews, others are focused more narrowly on the
authors' own research.
I particularly enjoyed David Lane's chapter on tumour-
suppressor genes and p53 and Karen Vousden's article on
cell transformation by human papillomaviruses. More than
50 pages in the volume are devoted to Epsten-Barr virus
(EBV) in relation to B-cell transformation and tumours,
whereas only two pages discuss NPC. This is in inverse ratio
to the prevalee of these tumours, and reveals the inclina-
tions of EBV specialists: lymphomas are easier to study than
carcinomas. Human adenoviruses, perhaps the most potent
oncogenc viruses of all when experimentally inoculated into
rodents, receive no mention at all, not even in George Klein's
introductory article. Perhaps they are deemed uninteresting
because they have not been associated with human cancer,
and not for want of trying. Yet this very negation is fas-
cinating and puzzling.
In the majority of well-studied viral cancers, the viral
genome plays a direct role in cell transformation and the
maintenance of the malignant phenotype. Integrated or
episomal viral genes are found in the tumour cell clones.
However, it is also becoming increasingly evident that viruses
can predispose to cancer indirectly. In this volume Ian Weller
illustrates HIV-related cancers with respect to immune
deficiency, while Jan Butel and colleagues discuss hver cancer
is relation to hepatitis B and C viruses, where chronic liver
damage may promote the emergence of the premalignant
clones of liver cells not infected by the virus.
Viral carcinogenesis may be direct or indirect, but in both
cases it can be prevented by immunisation against viral infec-
tion in the first place. Here, vaccination is discussed only in
relation to human and bovine papillomaviruses and feline
leukaemia virus. However, successful intervention studies
against hepatitis B virus are already under way in West
Africa, and time will tell if this leads to a significant drop in
the incidence of liver cancer. There appears to be a synergis-
tic relationship between virus and dietary carcinogens briefly
mentioned by Butel et al. for liver cancer and by Saveria
Campo for bovine papillomavirus type 4. A more thorough
discussion of co-factors in viral oncogenesis and the pro-
spects for prevention would not have come amiss. Nonethe-
less, for those intrested in the relation of viruses to cancer,
this volume provides a useful introduction to the field.
Professor RA Weiss
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Keating, Cambridge: Cambridge University Press, 1994, £50
hardback. ISBN: 0 521 44208 7.
This is the third volume in the series of reviews highlighting
growth areas in haematological oncology aimed at both
clinicians and research workers. The editors set themselves a
very difficult task in accepting such a wide remit and by and
large achieve a lot. However, such review texts become rather
piecemeal and lack the continuity of a monograph or text
committed to a specific topic. Consequently, in this volume
there is something for everyone but no topic is fully covered,
e.g. the epidemiology and viral aetiology of lymphomas are
included, but these are not put into the context of clinical
manifestation, immunophenotyping or pathology. For the
clinician reviewing a topic or for the hard-pressed examina-
tion candidate multiple texts are thus required, while the
researcher is more likely to find value in the bibliographies
and hence the original papers.
Those critical comments are applicable to all such texts
and must not detract from the well-written individual cont-
ributions, all by respected authorities in their field. Cart-
wright and McNally's Epidemiology ofNon-Hodgkin's Lym-
phomas is an excellent reference source, although so many
large tables make it difficult for the reader. I was confused by
the comment that 'no clear geographical associations
emerged' in childhood NHL and then the discussion of Bur-
kitt's lymphoma, for which there is a very characteristic
geographical variation. There were many other intriguing
items of interest which, as the authors suggest, do really
warrant further research. Onions has produced a very fine
and comprehensive overview of the viral aetiology of lym-
phoid malignancies, as has Myrtle Gordon on the stromal
microenvironment. The stroma is a complex area to study
but represents a real growing point of haematological
research, and this is a timely review of the subject. The
back-to-back chapters on myeloma therapy are especially
helpful to the practitioner deciding on therapy for an individ-
ual patient, and in particular Diana Sampson's final recom-
mendations are clear and very useful. Peripheral blood stem
cell transplantation is very much the flavour of the month,
for obvious reasons, but with the available growth factors
changing so rapidly texts such as this one inevitably becomeAA Oa~~~~~~k iAm
dated no matter how well written, as here by Juttner and To.
Alan Burnett's team's contribution to our understanding of
MDS is not inconsiderable, although the chapter here really
consists of a few laboratory titbits demonstrating pluripoten-
tial stem cell dysfunction. The brief French collaborative
chapter on retinoids summai the situation in APML well,
but holds little which most in the field do not already know.
Lorna Secker-Walker's very comprehensive chapter on
cytogenetics in ALL still leaves you with the feeling that we
are reading about phenomena. Am I alone in wishing that
the moleular geneticists, signales and protein experts
would collaborate with the cytoneticists to try to collec-
tively explain what we are observing and take our understan-
ding forward? A joint article by a number of those experts
would be a really useful contribution in a future volume.
Rogers' article on fungi is excellent and very timely: as we
intensify treatment, recognise and treat bacterial infection
earlier and for longer we are facing increasngly the threat of
fungal infection. The table on drug interactions, recommen-
dations for prophylaxis and strategies is of special practical
Importance.
In conclusion, this small tome is quite wide ranging in
topics and authors and must be seen in the context of being
one in a series. The editors must certainly be congratulated
on bringing together in the three volumes a tr ndous array
of individual talent.
Professor OB Eden
Practcl Approach to Head aud Neck Tmors
Jack Gluckman, Patrick Gullane and Jonas Johnson. Raven
Press: New York, 1994, 212 pp. ISBN 0-7817-0228-3.
This is a somewhat unusual book. It is written by three ENT
surgeons, two from USA and one from Canada. There are 15
chapters devoted to tumours at the various head and nwk
sites, inchlding thyroid and skcin. Each chapter is written by
one surgeon, who describes his own approach to manage-
ment of the tumours at the site in question. Comments from
the other two authors are in within the text In
each chapter aetiology, cinical behaviour and staging is des-
cribed very briefly and there is dikscussion of patient evahua-
tion by clinical examination and imaging. The majority of
each chapter is devoted to treatment. There is a list of
'suggested further reading' at the end of each chapter, but
there are no references as such. The authors make no attempt
to support their choice of treatment from published results.
Not surprisingly the emphasis is on surgical treatment.
Radical radiotherapy is not recommended for carcinoma at
any head and neck site except the nasopharynx or at any
stage; the one exception is caranoma of the hypopharynx
because the first author on this subject is the Canadian
surgeon.
The American author of the chapters on tumours of the
larynx and oropharynx decries the use of radical
radiotherapy for any stage of disease at either of these sites.
The Cnadinan author in his comments takes a diametricaly
opposite view. Throughout the book the role of radiotherapy
is regarded mainly as post-operative and there is little men-
tion of chemotherapy. There is no mention of multidiscip-
linary collaboration, either between surgical specialties or
between surgeons, radiation oncologists and cancer
physicians. One of the American surgeons writes: 'Most
patients will probably be treated in centres where facilities
vary in quality. The presence or absence of surgical expertise,
sophisicated radiotherapy and chemotherapy, and adequate
prosthetic facility all will dictate the optimal [my italics]
treatment of the patient in any given situation.' This is a
state of affairs which he seems to accept.
This book describes how ENT surgeons in the two count-
ries approach head and neck cancer. However, it offers no
explanation for the difference between them, which is mainly
the differences in health care delivery systems between USA
and Canada. It should be read in order to gain an insight
into North American surgical practice. It does not purport to
be a textbook of head and neck oncology and should not be
regarded as such.
Dr JM Henk, FRCR